Digital Diagnostics
Information
Digital Diagnostics (dxs.ai), formerly IDx, is a pioneering AI diagnostics company on a mission to transform the quality, equity, accessibility, and affordability of healthcare. Founded and led by Michael Abramoff, MD, PhD, a fellowship-trained retina specialist ophthalmoligist, neuroscientist and computer engineer. Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system with FDA De Novo authorization to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare. Learn more at www.dxs.ai.
